Related references
Note: Only part of the references are listed.Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug
Shawn D. Flanagan et al.
PHARMACOTHERAPY (2014)
Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections The ESTABLISH-1 Randomized Trial
Philippe Prokocimer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections
P. Prokocimer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Prodrugs-from Serendipity to Rational Design
Kristiina M. Huttunen et al.
PHARMACOLOGICAL REVIEWS (2011)
Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study
Katherine Dunn et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2011)
In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent
Ronda Schaadt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Trends in the Incidence of Methicillin-Resistant Staphylococcus aureus Infection in Children's Hospitals in the United States
Jeffrey S. Gerber et al.
CLINICAL INFECTIOUS DISEASES (2009)
Early Switch to Oral Treatment in Patients with Moderate to Severe Community-Acquired Pneumonia A Meta-Analysis
Zoe Athanassa et al.
DRUGS (2008)
Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care
Linda F. McCaig et al.
EMERGING INFECTIOUS DISEASES (2006)
Absorption rate limit considerations for oral phosphate prodrugs
T Heimbach et al.
PHARMACEUTICAL RESEARCH (2003)
Survey of infections due to Staphylococcus species:: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
DJ Diekema et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
